Something strange happened yesterday. Psychedelics unicorn Compass Pathways released data for the largest clinical trial ever conducted of a psilocybin drug. Not only did the drug seem to work, but the heavily anticipated data were “breathtaking” in the
The Psychedelic Landscape: Pharma, Tech, Decrim, Other
We’ve been writing about psychedelics on this blog now for three years. I believe the first article I wrote covered Food and Drug Administration (FDA) approval of Compass Pathway’s drug trial for COMP360, a psilocybin formulation that eventually was patented…
A Millionaire Couple is Threatening to Create a Magic Mushroom Monopoly
In her article, Olivia Goldhill discusses the how the company, Compass Pathways is promoting the use of psilocybin, the psychedelic compound in magic mushrooms as a treatment for depression. Recent studies have found that psilocybin makes a promising treatment for…